首页>
外国专利>
STATIN AND OMEGA 3 FATTY ACIDS (EPA, DHA AND DPA) FOR USE IN CARDIOVASCULAR DISEASES
STATIN AND OMEGA 3 FATTY ACIDS (EPA, DHA AND DPA) FOR USE IN CARDIOVASCULAR DISEASES
展开▼
机译:用于心血管疾病的他汀类和OMEGA 3种脂肪酸(EPA,DHA和DPA)
展开▼
页面导航
摘要
著录项
相似文献
摘要
A composition and a method of treatment utilizing a combination of statins (or HMG-CoA reductase inhibitors), a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, with mixtures of an omega-3 fatty acid formulation containing about 90% or more omega 3 fatty acids by weight including a combination of Eicosapentaenoic acid (EPA), Docosapentaenoic acid (DPA) and Docosahexaenoic acid (DHA) in a weight ratio of EPA:DHA of from 5.7 to 6.3, wherein the sum of the EPA, DHA and DPA represent about 82% by weight of the total formulation and about 92% of the total omega 3 fatty acid content of the composition are taught. EPA + DHA are about 80% of the total formulation and about 89% of the total omega 3 fatty acid content of the composition. The formulation may further contain specific amounts of arachidonic acid (AA) and of omega-3 fatty acids having 18 carbon atoms, including one or more of stearidonic acid (SDA) and alpha-linolenic acid (ALA). The application further teaches methods of administering such combinations, and is directed towards unit dosages of such combinations for the reduction of apolipoprotein-B levels.
展开▼